LOSS OF DEVELOPMENTAL PLASTICITY AFTER HEAD INJURY

头部受伤后发育可塑性丧失

基本信息

  • 批准号:
    7955649
  • 负责人:
  • 金额:
    $ 1.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Children in the United States have a higher chance of being killed or disabled by a traumatic brain injury (TBI) than by any other "disease". We have discovered that developmental TBI impairs the ability of young animals to interact with and benefit from rearing in an enriched environment (EE) [4;5]. The ability to interact and experience is a critical function underlying normal maturation; however, the mechanisms of this 'experience-dependent neuroplasticity' are only beginning to be understood. Excessive activation of the N-methyl-D-aspartate receptor (NMDAR) occurs following TBI and can lead to cell dysfunction and death [6;7]. However, too little activation can impair normal development and blunt recovery from injury [8]. The NMDAR is intimately involved with a unique growth factor, brain-derived neurotrophic factor (BDNF). Increases in BDNF occur in response to specific environmental experiences, such as rearing in an EE or exercise [9;10;11], and these increases are associated with enhanced plasticity and cognition. We propose that early TBI results in a reduction of developmental potential, and that this impairment occurs via a mechanism where physiological activation of the NMDAR/BDNF system is deranged by a pathological overstimulation of these molecular pathways. To study this, the following 5 specific aims are put forth: (1) to characterize the molecular profile of the NMDAR/BDNF system in response to EE rearing in normal and injured animals; (2) to demonstrate that excessive NMDAR activation is the trigger for deleterious molecular changes by blocking the NMDAR at the time of injury and restoring the 'normal' experience-dependent NMDAR/BDNF response; (3) to activate molecular plasticity pathways post-injury through voluntary exercise; (4) to demonstrate that restoring a normal NMDAR/BDNF response results in anatomical and behavioral improvements; and finally (5) to endogenously enhance plasticity at the appropriate time post-injury through exercise, rescue the normal NMDAR/BDNF response, and improve neurobehavioral outcome.
该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员(PI)可能已经从其他NIH来源获得了主要资金, 因此,可以在其他清晰的条目中表示。列出的机构是 对于中心,这不一定是调查员的机构。 与其他任何“疾病”相比,美国的儿童被创伤性脑损伤(TBI)杀死或残疾的机会更高。我们已经发现,发育性TBI损害了幼小动物与养育环境(EE)(EE)[4; 5]相互作用和受益的能力。互动和经验的能力是正常成熟的关键功能。但是,这种“依赖经验的神经可塑性”的机制才被开始理解。 N-甲基-D-天冬氨酸受体(NMDAR)的过度激活发生在TBI之后,可导致细胞功能障碍和死亡[6; 7]。但是,太少的激活会损害正常发育和受伤的钝性恢复[8]。 NMDAR与独特的生长因子,脑衍生的神经营养因子(BDNF)密切相关。 BDNF的增加是响应特定的环境经历而发生的,例如在EE或运动中饲养[9; 10; 11; 11],这些增加与增强的可塑性和认知有关。我们建议早期TBI导致发育潜力的降低,并且这种损害是通过一种机制发生的,在这种机制中,NMDAR/BDNF系统的生理激活因这些分子途径的病理过度刺激而破坏了。为了研究这一点,提出了以下5个特定目标:(1)表征NMDAR/BDNF系统的分子谱,以响应正常和受伤的动物中的EE饲养; (2)证明过多的NMDAR激活是通过在损伤时阻止NMDAR并恢复“正常”经验依赖性的NMDAR/BDNF响应来阻止NMDAR的触发因素; (3)通过自愿运动在伤害后激活分子塑性途径; (4)证明恢复正常的NMDAR/BDNF响应会导致解剖和行为改善;最后(5)通过运动后在适当的时间内增强可塑性,挽救正常的NMDAR/BDNF响应并改善神经行为的结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID A HOVDA其他文献

DAVID A HOVDA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID A HOVDA', 18)}}的其他基金

LOSS OF DEVELOPMENTAL PLASTICITY AFTER HEAD INJURY
头部受伤后发育可塑性丧失
  • 批准号:
    8171042
  • 财政年份:
    2010
  • 资助金额:
    $ 1.36万
  • 项目类别:
TBI-Induced Cerebral Metabolic Depression and Recovery
TBI 引起的脑代谢抑制和恢复
  • 批准号:
    7630873
  • 财政年份:
    2009
  • 资助金额:
    $ 1.36万
  • 项目类别:
TBI-Induced Cerebral Metabolic Depression and Recovery
TBI 引起的脑代谢抑制和恢复
  • 批准号:
    8246433
  • 财政年份:
    2009
  • 资助金额:
    $ 1.36万
  • 项目类别:
TBI-Induced Cerebral Metabolic Depression and Recovery
TBI 引起的脑代谢抑制和恢复
  • 批准号:
    8284886
  • 财政年份:
    2009
  • 资助金额:
    $ 1.36万
  • 项目类别:
TBI-Induced Cerebral Metabolic Depression and Recovery
TBI 引起的脑代谢抑制和恢复
  • 批准号:
    8043507
  • 财政年份:
    2009
  • 资助金额:
    $ 1.36万
  • 项目类别:
TBI-Induced Cerebral Metabolic Depression and Recovery
TBI 引起的脑代谢抑制和恢复
  • 批准号:
    8460073
  • 财政年份:
    2009
  • 资助金额:
    $ 1.36万
  • 项目类别:
TBI-Induced Cerebral Metabolic Depression and Recovery
TBI 引起的脑代谢抑制和恢复
  • 批准号:
    7789433
  • 财政年份:
    2009
  • 资助金额:
    $ 1.36万
  • 项目类别:
LOSS OF DEVELOPMENTAL PLASTICITY AFTER HEAD INJURY
头部受伤后发育可塑性丧失
  • 批准号:
    7724316
  • 财政年份:
    2008
  • 资助金额:
    $ 1.36万
  • 项目类别:
LOSS OF DEVELOPMENTAL PLASTICITY AFTER HEAD INJURY
头部受伤后发育可塑性丧失
  • 批准号:
    7627670
  • 财政年份:
    2007
  • 资助金额:
    $ 1.36万
  • 项目类别:
LOSS OF DEVELOPMENTAL PLASTICITY AFTER HEAD INJURY
头部受伤后发育可塑性丧失
  • 批准号:
    7369389
  • 财政年份:
    2006
  • 资助金额:
    $ 1.36万
  • 项目类别:

相似国自然基金

非晶态高聚物热力学本构模型及其在变形局域化行为表征方面的应用
  • 批准号:
    11872170
  • 批准年份:
    2018
  • 资助金额:
    63.0 万元
  • 项目类别:
    面上项目
单分散温度/pH双重响应的Janus微/纳米凝胶的制备、组装行为及在介入栓塞材料方面的应用研究
  • 批准号:
    51103051
  • 批准年份:
    2011
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
智力超常儿童的基因分型的初步研究
  • 批准号:
    30670716
  • 批准年份:
    2006
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 1.36万
  • 项目类别:
Amnion cell secretome mediated therapy for traumatic brain injury
羊膜细胞分泌组介导的创伤性脑损伤治疗
  • 批准号:
    10746655
  • 财政年份:
    2023
  • 资助金额:
    $ 1.36万
  • 项目类别:
BDNF in the Reward Circuit for DBS-Induced Opioid Extinction
DBS 引起的阿片类药物灭绝的奖赏回路中的 BDNF
  • 批准号:
    10629686
  • 财政年份:
    2023
  • 资助金额:
    $ 1.36万
  • 项目类别:
Impacts of morphine and HIV-Tat exposures and dimethylfumarate treatment on brain BDNF and mitochondrial and behavioral dysfunction.
吗啡和 HIV-Tat 暴露以及富马酸二甲酯治疗对大脑 BDNF 以及线粒体和行为功能障碍的影响。
  • 批准号:
    10619675
  • 财政年份:
    2023
  • 资助金额:
    $ 1.36万
  • 项目类别:
Optimizing Music-Based Interventions for Stroke Rehabilitation
优化基于音乐的中风康复干预措施
  • 批准号:
    10607156
  • 财政年份:
    2022
  • 资助金额:
    $ 1.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了